Crowdfunding in Singapore raises RM10.11 million needed to buy drug to treat baby with rare genetic disorder


Baby Zayn was diagnosed with Type 1 spinal muscular atrophy about five weeks after he was born. - PHOTO: SYAHIRAH YAKUB

SINGAPORE, Nov 12 (The Straits Times/ANN): A five-month-old boy facing immobility or even death because of a rare genetic disorder may get a new lease on life after his parents successfully raised the S$3 million (RM10.11 million) needed to treat his condition.

Baby Zayn – who was diagnosed with Type 1 spinal muscular atrophy (SMA) about five weeks after he was born – will be able to get the drug Zolgensma by early December, his parents, Mr Nabeel Salim Abdat and Ms Syahirah Yakub, told The Sunday Times.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Fuel crisis drives up Lao inflation to 9.7%
Vietnam refinery boosting jet fuel production
Philippine farmers turn to ‘Pasyon’ to sustain fight for land and justice
Asian stocks edge higher in holiday-thinned trading
Indonesian airlines renew call to raise fare cap as jet fuel prices jump 70%
BOJ keeps rate hike door open even as Iran war squeezes firms
Thai household debt climbs to 86.7% of GDP, exposing deeper economic fragility
Australians cancel Easter travel as worries mount over fuel crisis
Bangladesh cuts working hours to save energy amid Middle East crisis
New forces reshape how China buys

Others Also Read